MOG and myelitis: Seven patients (7/28, 25.0%) in the AQP4-ON group had a clinical history of myelitis, with myelitis occurring less frequently in the MOG-ON (1/26, 3.8%) and IDON (0/29, 0.0%) patients (P = 0.002).